Your cart:£0.00(0 items) Check yourbonu$
Site search:
Categories list

Get Epivir (Lamivudine)

Generic Epivir is used for treating HIV infection in combination with other medicines.

PackagePricePer pillSavingsOrder
100mg × 30 pills£55.56£1.85Add to cart
100mg × 60 pills£84.30£1.40£26.82Add to cart
100mg × 90 pills£113.03£1.26£53.64Add to cart
100mg × 120 pills£141.77£1.18£80.46Add to cart

PackagePricePer pillSavingsOrder
150mg × 30 pills£59.01£1.97Add to cart
150mg × 60 pills£91.19£1.52£26.82Add to cart
150mg × 90 pills£123.38£1.37£53.64Add to cart
150mg × 120 pills£155.56£1.30£80.46Add to cart
Most popular quantity.

Products from the same category

Lamivudine tablet

What is this medicine?

LAMIVUDINE is an antiretroviral drug. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

What should my health care professional know before I take this medicine?

They need to know if you have any of these conditions:

  • kidney disease
  • liver disease
  • an unusual or allergic reaction to lamivudine, other medicines, foods, dyes, or preservatives
  • pregnant or trying to get pregnant
  • breast-feeding

How should I take this medicine?

Take this medicine by mouth with a glass of water. You may take this medicine with or without food. Take your medicine at regular intervals. Do not take your medicine more often than directed. For your anti-HIV therapy to work as well as possible, take each dose exactly as prescribed. Do not skip doses or stop your medicine even if you feel better. Skipping doses may make the HIV virus resistant to this medicine and other medicines. Do not stop taking except on your doctor's advice.

Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

If you miss a dose, take it as soon as you can. If it is almost time for your next dose, take only that dose. Do not take double or extra doses.

What may interact with this medicine?

  • emtricitabine
  • other lamivudine medicines
  • ribavirin
  • sulfamethoxazole; trimethoprim, SMX-TMP
  • trimethoprim
  • zalcitabine, ddC

This list may not describe all possible interactions. Give your health care providers a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while taking this medicine?

Visit your doctor or health care professional for regular check ups. Discuss any new symptoms with your doctor. You will need to have important blood work done while on this medicine.

HIV is spread to others through sexual or blood contact. Talk to your doctor about how to stop the spread of HIV.

If you have hepatitis B and HIV, talk to your doctor if you plan to stop this medicine. The symptoms of hepatitis B may get worse if you stop this medicine.

What side effects may I notice from this medicine?

Side effects that you should report to your doctor or health care professional as soon as possible:

  • allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
  • breathing difficulties
  • depressed mood
  • muscle pain or weakness
  • nausea, vomiting, unusual stomach upset or pain
  • pain, tingling, numbness in the hands or feet
  • unusually weak or tired
  • yellowing of the skin or eyes

Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):

  • cough
  • diarrhea
  • difficulty sleeping
  • dizziness
  • hair loss
  • headache
  • loss of appetite
  • runny, stuffy nose
  • weight gain around waist, back, or thinning of face, arms, legs

This list may not describe all possible side effects.

Where can I keep my medicine?

Keep out of the reach of children.

Store at room temperature between 15 and 30 degrees C (59 and 86 degrees F). Throw away any unused medicine after the expiration date.

Choose Your language:
Social bookmarks:
Testimonials
Yes I received the order.. It was a good deal . 60 pills for \$119. Is this offer still in place?? - Thanks!
Read more »

Our billing is certified by:

Secure shopping certificates


Special Offer!

This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update
Updated Dosing, Drug Interactions Added to Epivir Labeling - Monthly Prescribing Reference
Monthly Prescribing ReferenceUpdated Dosing, Drug Interactions Added to Epivir LabelingMonthly Prescribing ReferenceThe labeling for Epivir Oral Solution now recommends a higher total daily dosage from 8mg/kg/day to 10mg/kg/day in HIV-1 infected pediatric patients aged ≥3 months
India's commitment to 'Ending the AIDS' epidemic - The Pharma Letter - The Pharma Letter
The Pharma LetterIndia's commitment to 'Ending the AIDS' epidemic - The Pharma LetterThe Pharma LetterThe occasion of World AIDS Day was as good as any for India to launch a National Strategic Plan 2017-24, aimed at eradicating HIV/ AIDS by 2030
Gilead & 3 Other Drug Stocks in Focus this World AIDS Day - Nasdaq
Gilead & 3 Other Drug Stocks in Focus this World AIDS DayNasdaqThese include multi-class combination products (Atripla, Complera, Stribild), nucleoside reverse transcriptase inhibitors (NRTIs - Combivir, Epivir, Truvada, Viread), non-nucleoside reverse transcriptase inhibitors (NNRTIs - Edurant, Sustiva), protease
GSK's ViiV gets US okay for two-drug HIV regimen - PMLiVE
PMLiVEGSK's ViiV gets US okay for two-drug HIV regimenPMLiVEThe company is also testing the combination of dolutegravir and Epivir (lamivudine) in phase III trials for treatment-naive HIV patients, and the pairing of integrase inhibitor cabotegravir and rilpivirine that could be given as a monthly or bi-monthly
Centralux Ltd
bookmark Bookmark this site
Subscribe to the News